Frazier Management as of March 31, 2020
Portfolio Holdings for Frazier Management
Frazier Management holds 25 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 35.6 | $314M | 11M | 29.80 | |
| Phathom Pharmaceuticals (PHAT) | 21.3 | $188M | 7.3M | 25.82 | |
| Passage Bio (PASG) | 8.9 | $79M | 5.0M | 15.75 | |
| Iovance Biotherapeutics (IOVA) | 5.9 | $52M | 1.8M | 29.93 | |
| Mirum Pharmaceuticals (MIRM) | 5.7 | $50M | 3.6M | 14.00 | |
| Krystal Biotech (KRYS) | 4.4 | $39M | 895k | 43.24 | |
| Anaptysbio Inc Common (ANAB) | 3.7 | $33M | 2.3M | 14.13 | |
| Translate Bio | 2.5 | $22M | 2.2M | 9.97 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.7 | $15M | 944k | 16.33 | |
| Adverum Biotechnologies | 1.4 | $13M | 1.3M | 9.77 | |
| Gritstone Oncology Ord (GRTSQ) | 1.4 | $12M | 2.1M | 5.82 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $11M | 991k | 10.97 | |
| Trillium Therapeutics, Inc. Cmn | 1.1 | $9.6M | 2.4M | 3.91 | |
| Alpine Immune Sciences | 0.8 | $7.4M | 2.6M | 2.88 | |
| Millendo Therapeutics | 0.8 | $7.4M | 1.4M | 5.28 | |
| Aptinyx | 0.8 | $6.9M | 3.2M | 2.16 | |
| Iterum Therapeutics | 0.5 | $4.2M | 1.5M | 2.71 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $3.3M | 1.3M | 2.48 | |
| Allena Pharmaceuticals | 0.4 | $3.2M | 3.3M | 0.96 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $2.9M | 210k | 13.95 | |
| Entasis Therapeutics Holdings Ord | 0.3 | $2.8M | 1.0M | 2.64 | |
| Nabriva Therapeutics | 0.3 | $2.4M | 4.3M | 0.58 | |
| Vtv Therapeutics Inc- Cl A | 0.2 | $2.0M | 1.1M | 1.91 | |
| Sierra Oncology | 0.2 | $2.0M | 203k | 9.82 | |
| Bellicum Pharmaceuticals | 0.1 | $495k | 105k | 4.71 |
